Solve Therapeutics, Inc.
Belmont, US · Founded 2021 · Delaware corporation · 1 known investors
Founders & leadership
LM
Langdon MillerExecutive
DJ
David JohnsonExecutive
CD
Clayton D. KnoxExecutive
Board
PC
Peter ColabuonoBoard director
AC
Alan ColowickBoard director
JP
Jason PittsBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$162.1M disclosed across 3 rounds · 2021–2025
▶$48.2MraisedNov 2025 · 16 investors · BiotechnologyRule 506(b)
▶$48.2MraisedNov 2025 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel McHughDirector
- Langdon MillerExecutive Officer
- David JohnsonExecutive Officer, Director
- Clayton D. KnoxExecutive Officer
- Robert MittendorffDirector
- Alan ColowickDirector
- Jason PittsDirector
- Peter ColabuonoDirector
- Offering amount
- $120.5M
- Amount sold
- $48.2M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$50.4MraisedDec 2024 · 10 investors · BiotechnologyRule 506(b)
▶$50.4MraisedDec 2024 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter ColabuonoDirector
- Langdon MillerExecutive Officer
- Alan ColowickDirector
- David JohnsonExecutive Officer, Director
- Clayton D. KnoxExecutive Officer
- Jason PittsDirector
- Offering amount
- $75.6M
- Amount sold
- $50.4M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$63.5MraisedJan 2022 · 11 investors · BiotechnologyRule 506(b)
▶$63.5MraisedJan 2022 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter ColabuonoDirector
- Langdon MillerExecutive Officer
- Alan ColowickDirector
- David JohnsonExecutive Officer, Director
- Offering amount
- $126.5M
- Amount sold
- $63.5M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Solve Therapeutics, Inc.'s investors?
- Solve Therapeutics, Inc.'s investors include B4 Capital.
- How much funding has Solve Therapeutics, Inc. raised?
- Solve Therapeutics, Inc. has disclosed $162.1M raised across 3 rounds.
- Where is Solve Therapeutics, Inc. headquartered?
- Solve Therapeutics, Inc. is headquartered in Belmont, US.